Endovascular Arteriovenous Fistula Creation-Review of Current Experience

Alexandros Mallios; Jan Malik; William C Jennings

doi:10.3390/diagnostics12102447

Endovascular Arteriovenous Fistula Creation-Review of Current Experience

Diagnostics (Basel). 2022 Oct 10;12(10):2447. doi: 10.3390/diagnostics12102447.

Authors

Alexandros Mallios¹, Jan Malik², William C Jennings³

Affiliations

¹ Department of Vascular Surgery, Groupe Hospitalier Paris Saint Joseph, 75014 Paris, France.
² Department Internal Medicine and General University Hospital, First Medical Faculty, Charles University, U Nemocnice 1, 128 08 Prague, Czech Republic.
³ Department of Surgery School of Community Medicine, Tulsa, OK 74135, USA.

Abstract

Functioning vascular access is an essential element for life-saving hemodialysis therapy. A surgically-created arteriovenous fistula has been considered the best option for many years. Recently, two manufacturers developed systems for percutaneous/endovascular creation of an arteriovenous fistula (WavelinQ and Ellipsys). We provide a review of the available experience with these systems and discuss advantages and disadvantages.

Keywords: Ellipsys; EndoAVF; WavelinQ; percutaneous AVF.

Publication types

Review

Grants and funding

J.M. is supported by the Ministry of Health, Czech Republic-DRO (General University Hospital in Prague-VFN), 00064165 and by Charles University Research program, “Cooperation—Cardiovascular Science”.